GLP-1 drug prescribed to woman with eating disorder via telehealth sparks calls for regulation
Experts are calling for greater oversight of telehealth clinics after an online clinic prescribed injectable weight-loss medications to…
Secret shopper study reveals questionable telehealth GLP-1 practices
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Legal fights brewing over the basic business model of telehealth
In less than a decade, telehealth has expanded from a sideshow of health care to an industry worth…
To reinvent cancer care, Color Health is going virtual first, AI-driven
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
NC moves to rein in soaring autism therapy costs
by Jaymie Baxley, North Carolina Health News April 27, 2026 By Jaymie Baxley Meredith McCumbee has seen firsthand…
Discount telehealth visits raise concerns about pharma company ties
The little pink pill recently got a retail boost. Addyi, a drug that treats low libido in premenopausal…
VA Research Wrap Up: New findings on chronic pain management, smoking and cardiac rehab
VA’s Office of Research and Development recently published three News Briefs highlighting research findings on a chronic pain management tool…
Patient a minute late has appointment canceled at RRH Geneva | Health
GENEVA — It is not out of the ordinary for a patient or a doctor to be late…
Family files wrongful death lawsuit against Yale New Haven Health
The parents of a 26-year-old dental student are suing the hospital where he died, saying that the doctor…
FDA telehealth crackdown highlights role of national doctor networks
The Food and Drug Administration is cracking down on telehealth companies’ marketing of compounded versions of weight loss…
How Hims has transformed medicine in a few short years
As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front…
Media Watch targets Dr Nick Coatsworth for ‘disclosure failures’ after promoting GLP-1 receptor agonists on TV
Dr Nick Coatsworth has come under fire for promoting GLP-1 receptor agonist medications on television without consistently disclosing that…